My two cents about the disclaimer and the Relief response to @Mav's email.
I personally would not draw any conclusions from the emailed reply.
I have a company with three friends and from my 10-year experience as a director the one thing I am absolutely certain is true worldwide is that what goes out can never contradict the official line otherwise you paint a terrible image to your investors, bankers, and you run foul of your lawyers.
At the moment the latest NRx SEC filings imply a refusal by Relief to go beyond what they are contractually meant to pay, something which is stated very clearly in the same filings : "it is NRx responsibility not to exceed 30% over budget".
So, purely from a financial point of view, there is actually no dispute any more - it was interesting to read the change of wording in the latest filing compared to the filings earlier this year which riled up Relief and got them to issue their own PR. The latest filings clearly point out that Relief has paid 10.9 million, $100K over the over-budget, there is still a loan that NRx is paying back to Relief until April, and what is made very clear in those filings is that Relief have paid everything they were meant to pay, even the 30% over-budget.
Moving over to the other points of contention : data and patents. Relief has all the patents and covers all formulations, whether intravenous (Mondobiotech) or inhaled as per Advita's worldwide patent of 5th August.
With regards to the data, I go back to my first point : lawyers.
As per my last post 10 days ago or so, I believe that behind the scene the $30 million direct placement that HC Wainwright negotiated exclusively for NRx had some heavy input by you know who and that informal behind the scenes discussions between NRx, Ram, and GEM would have put some conditions on that $30 million. That $30 million placement would never have happened any other way.
Problem : until future NRx SEC filings and/or lawyer verified statements from NRx, and a variety of other legal statements, all answers to an email from us retail investors will come back with statements identical to the Relief disclaimer at the bottom of their Press Release on Monday.
I personally am not losing ANY sleep on this whatsoever : in this game of poker the Relief's hand is in full view of everyone and is loaded with all four aces. ~ Ilka, Y@h00 RLFTF finance conversations
